

Nephrocare Health Services Limited dba NephroPlus has raised ₹871.048 crore (~$95.99 million) from an initial public offering, comprising a fresh issue of ₹353.405 crore and an offer for sale of ₹517.643 crore.
Shardul Amarchand Mangaldas & Co advised NephroPlus on this IPO. SAM acted on Indian law aspects of the transaction, advising on the drafting and regulatory compliance for the IPO, including coordination with multiple domestic and international stakeholders and supporting the company through the prospectus filing and listing process.
The transaction team was led by Prashant Gupta (National Practice Head – Capital Markets) and Devi Prasad Patel (Partner), with assistance from Associates Divya Dhawan, Satakshi N. Dixit and Arjun Bhatia.
Khaitan & Co advised Promoter selling shareholder Investcorp on this IPO.
The transaction team consisted of Thomas George (Partner), Suman Prabhu (Partner) and Anand Sivasankaran (Associate).
Cyril Amarchand Mangaldas advised selling shareholder International Finance Corporation on this IPO.
Aashima Johur (Partner), with support from Associates Rishi Nandkeolyar and Abhinav Singh Chauhan advised on capital markets related aspects.
Ravindra Bandhakavi (Senior Partner), Poornima Singh (Partner) and Radhika Shukla (Senior Associate) advised on general corporate aspects.
Trilegal advised the book running lead managers ICICI Securities Limited, Ambit Private Limited, IIFL Capital Services Limited and Nomura Financial Advisory and Securities (India) Private Limited, on this IPO.
The transaction team was led by Richa Choudhary (Partner) and Murtaza Zoomkawala (Partner), and comprised Maitreya Rajurkar (Counsel), Shivayana Balodia (Senior Associate) and Associates Rainika Malhotra, Dinank Bhanot, Yatin Shikharpuri, and Arnab Goswami.
NephroPlus is Asia's largest dialysis network with over 490 clinics across India and expansions into Nepal, the Philippines, and Uzbekistan. It provides a comprehensive range of renal care services, including in-clinic hemodialysis, serving thousands of patients with reliable and accessible dialysis treatment.
If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.